Clinical Trial Update: Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study comparing teriflunomide to placebo during gluten challenge in people with celiac disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

Sponsor: Oslo University Hospital | Conditions: Celiac Disease | Phase 1, Phase 2 | Status: COMPLETED